PE20070175A1 - Derivados de n-[(1,5-difenil-1h-pirazol-3-il)metil]sulfonamida y su preparacion - Google Patents
Derivados de n-[(1,5-difenil-1h-pirazol-3-il)metil]sulfonamida y su preparacionInfo
- Publication number
- PE20070175A1 PE20070175A1 PE2006000807A PE2006000807A PE20070175A1 PE 20070175 A1 PE20070175 A1 PE 20070175A1 PE 2006000807 A PE2006000807 A PE 2006000807A PE 2006000807 A PE2006000807 A PE 2006000807A PE 20070175 A1 PE20070175 A1 PE 20070175A1
- Authority
- PE
- Peru
- Prior art keywords
- methyl
- pirazol
- alkyl
- dichlorophenyl
- chlorophenyl
- Prior art date
Links
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical class [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 title abstract 6
- 150000003456 sulfonamides Chemical class 0.000 title abstract 2
- 229940124530 sulfonamide Drugs 0.000 title 1
- -1 2,4-DICHLOROPHENYL Chemical class 0.000 abstract 3
- GEAXLHPORCRESC-UHFFFAOYSA-N chlorocyclohexatriene Chemical class ClC1=CC=C=C[CH]1 GEAXLHPORCRESC-UHFFFAOYSA-N 0.000 abstract 3
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical class [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- SLRMQYXOBQWXCR-UHFFFAOYSA-N 2154-56-5 Chemical class [CH2]C1=CC=CC=C1 SLRMQYXOBQWXCR-UHFFFAOYSA-N 0.000 abstract 1
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical class O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 206010015037 epilepsy Diseases 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical group 0.000 abstract 1
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical class [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
SE REFIERE A COMPUESTOS N-[(1,5-DIFENIL-1H-PIRAZOL-3-IL)METIL]SULFONAMIDAS DE FORMULA (I), EN DONDE R1 ES ALQUILO(C1-C12), CARBOCICLO NO AROMATICO(C3-C12), METILO SUSTITUIDO CON CARBOCICLICO NO AROMATICO, FENILO, BENCILO, ENTRE OTROS Y OPCIONALMENTE SUSTITUIDOS; R2 ES H, ALQUILO(C1-C4) O ALQUIL(C1-C4)SULFONILO; R3 ES CIANO, HIDROXILO, ALCOXI(C1-C4), ENTRE OTROS; R4 Y R5 SON INDEPENDIENTEMENTE FENILO OPCIONALMENTE SUSTITUIDOS CON HALOGENO, ALQUILO(C1-C7), ENTRE OTROS. SON PREFERIDOS: N- {[5-(4-CLOROFENIL)-4-CIANO-1-(2,4-DICLOROFENIL)-1H-PIRAZOL-3-IL]METIL}-3-CIANOBENCENOSULFONAMIDA, N- {[5-(4-CLOROFENIL)-4-CIANO-1-(2,4-DICLOROFENIL)-1H-PIRAZOL-3-IL]METIL}-3-TRIFLUOROBENCENOSULFONAMIDA, N- {[5-(4-CLOROFENIL)-4-CIANO-1-(2,4-DICLOROFENIL)-1H-PIRAZOL-3-IL]METIL}-3-TRIFLUOROMETOXIBENCENOSULFONAMIDA, ENTRE OTROS. TAMBIEN SE REFIERE A UNA COMPOSICION FARMACEUTICA Y UN PROCEDIMIENTO DE PREPARACION. LOS COMPUESTOS DESCRITOS SON ANTAGONISTAS DE LOS RECEPTORES DE CANABINOIDES CB1 Y SON UTILES PARA EL TRATAMIENTO DE MIGRANA, EPILEPSIA, ALZHEIMER, PARKINSON, TEMBLORES, DISTONIA
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0507360A FR2888236B1 (fr) | 2005-07-08 | 2005-07-08 | Derives de n-[(1,5-diphenyl-1h-pyrazol-3-yl)methyl] sulfonamide, leur preparation et leur application en therapeutique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20070175A1 true PE20070175A1 (es) | 2007-02-23 |
Family
ID=35872804
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2006000807A PE20070175A1 (es) | 2005-07-08 | 2006-07-06 | Derivados de n-[(1,5-difenil-1h-pirazol-3-il)metil]sulfonamida y su preparacion |
Country Status (7)
| Country | Link |
|---|---|
| AR (1) | AR057660A1 (es) |
| DO (1) | DOP2006000163A (es) |
| FR (1) | FR2888236B1 (es) |
| GT (1) | GT200600296A (es) |
| PE (1) | PE20070175A1 (es) |
| TW (1) | TW200800910A (es) |
| UY (1) | UY29657A1 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7297710B1 (en) | 2006-07-12 | 2007-11-20 | Sanofi-Aventis | Derivatives of N-[(1,5-diphenyl-1H-pyrazol-3-yl)methyl]sulfonamide, their preparation and their application in therapeutics |
| FR2911136B1 (fr) * | 2007-01-05 | 2009-02-20 | Sanofi Aventis Sa | Derives de n-(4-cyano-1h-pyrazol-3-yl)methylamine substitues leur preparation et leur application en therapeutique. |
| JP4994295B2 (ja) * | 2007-04-20 | 2012-08-08 | 田辺三菱製薬株式会社 | 医薬組成物 |
| CN113200850A (zh) * | 2021-05-08 | 2021-08-03 | 渭南师范学院 | 一种α-酰氧基酮化合物的制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2713225B1 (fr) * | 1993-12-02 | 1996-03-01 | Sanofi Sa | N-pipéridino-3-pyrazolecarboxamide substitué. |
| US7247628B2 (en) * | 2002-12-12 | 2007-07-24 | Pfizer, Inc. | Cannabinoid receptor ligands and uses thereof |
| FR2856683A1 (fr) * | 2003-06-25 | 2004-12-31 | Sanofi Synthelabo | Derives de 4-cyanopyrazole-3-carboxamide, leur preparation et leur application en therapeutique |
-
2005
- 2005-07-08 FR FR0507360A patent/FR2888236B1/fr not_active Expired - Fee Related
-
2006
- 2006-07-06 PE PE2006000807A patent/PE20070175A1/es not_active Application Discontinuation
- 2006-07-06 GT GT200600296A patent/GT200600296A/es unknown
- 2006-07-07 DO DO2006000163A patent/DOP2006000163A/es unknown
- 2006-07-07 UY UY29657A patent/UY29657A1/es unknown
- 2006-07-07 AR ARP060102940A patent/AR057660A1/es not_active Application Discontinuation
- 2006-07-07 TW TW095124925A patent/TW200800910A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR057660A1 (es) | 2007-12-12 |
| GT200600296A (es) | 2007-03-14 |
| FR2888236A1 (fr) | 2007-01-12 |
| TW200800910A (en) | 2008-01-01 |
| FR2888236B1 (fr) | 2007-09-21 |
| UY29657A1 (es) | 2007-01-31 |
| DOP2006000163A (es) | 2007-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20061353A1 (es) | Compuestos de sulfonamida-tiazolopiridina como activadores de glucocinasa | |
| PE20080830A1 (es) | Compuestos derivados de sulfonilo que modulan el receptor cb2 | |
| NO20076498L (no) | Derivater av 4-(2-amino-1-hydroksyetyl)fenol som agonister av den betta2-adrenerge reseptoren | |
| PE20060361A1 (es) | Compuestos heterociclicos como inhibidores de la cinesina mitotica | |
| NO20074390L (no) | Forsterket bimatoprost oye-opplosning | |
| PE20040164A1 (es) | Mimeticos de glucocorticoides, procedimientos para su preparacion y composiciones farmaceuticas | |
| PE20040775A1 (es) | DERIVADOS DE INDOL COMO AGONISTAS DE ADRENORECEPTORES ß2 | |
| PE20060627A1 (es) | Derivados de pirazol condensado como agonistas de los receptores cannabinoides cb1 y/o cb2 | |
| EA200700047A1 (ru) | Новые алкильные производные в качестве метаботропных рецепторов глутамата | |
| PE20071254A1 (es) | Derivados de sulfonamidas como agentes moduladores de los receptores de orexina y su preparacion | |
| PE20050598A1 (es) | Compuestos moduladores de cb1 | |
| PE20060777A1 (es) | Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas | |
| HRP20090162T1 (en) | Quinolinone-carboxamide compounds as 5-ht4 receptor agonists | |
| PE20060401A1 (es) | Derivados de n-(2-bencil)-2-fenil-butanamidas y propanamidas como moduladores del receptor de androgeno | |
| PE20021094A1 (es) | Derivados de ciclohexano-1,4-diamina sustituidos | |
| PE20081530A1 (es) | Nuevos compuestos 617 | |
| PE20051173A1 (es) | Compuestos azabiciclico (3.1.0) hexanos como moduladores de receptores de dopamina d3 | |
| PE20070519A1 (es) | Derivados de fenilmorfolina y feniltiomorfolina como agonistas de adrenoreceptores alfa 2c | |
| AR064459A1 (es) | Derivados de sulfonamida | |
| CR8505A (es) | Derivados de (3-oxo-3,4-dihidroquinoxalin-2-il-amino)-benzamida y compuesto relacionado, como inhibidores de glucogeno fosforilasa para el tratamiento de la diabetes y obesidad | |
| ATE411289T1 (de) | Indolalaninderivate als selektive s1p4-agonisten | |
| PE20140968A1 (es) | Derivados de benzamida sustituida | |
| AR068115A1 (es) | Derivado del acido pirazolcarboxilico metodo de produccion del mismo y fungicida | |
| PE20060610A1 (es) | Derivados tetraciclicos como moduladores de los receptores de estrogeno | |
| PE20081496A1 (es) | Derivados de 2,5-dihidro-3-h-pirazolo[4,3-c]piridazin-3-ona sustituidos como antagonistas de los receptores cb1 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |